Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Baird

Albemarle Sits at the Center of Lithium’s Next Cycle

Albemarle stock surged in 2025, but analysts see further upside. Rising lithium prices, storage demand, and disciplined supply could shape ALB in 2026

20,000 Reasons to Consider Selling Rivian Stock Here

20,000 Reasons to Consider Selling Rivian Stock Here

Rivian is recalling nearly 20,000 vehicles due to a toe-link issue.

2025 Wasn’t an Easy Year for Tesla Stock, but Baird Says It’s a ‘Core Holding’ for 2026 Anyways

2025 Wasn’t an Easy Year for Tesla Stock, but Baird Says It’s a ‘Core Holding’ for 2026 Anyways

Tesla enters 2026 as a high‑beta “prove‑it” story, with record free cash flow and new energy and AI levers offset by falling deliveries, a rich multiple, and a consensus "Hold" rating.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Meta Stock: Why Investors Are Terrified ChatGPT Will Steal Facebook's Users

Meta Stock 2026: Why analysts see 'wounded sentiment' as a buying opportunity. Explore the AI battleground, Baird's $815 price target, and 2026 growth risks.

International Business Times UK

This Analyst Just Raised Their Micron Stock Price Target by 50%. Should You Buy Shares Here?

After a strong run-up this year, Micron is winning fresh confidence from Wall Street bulls like Needham. Should investors chase the momentum, or wait for a better entry?

Broadcom To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Uber To Rally Around 43%? Here Are 10 Top Analyst Forecasts For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

inkl

Read news from The Economist, FT, and more,
with one subscription

Applied Materials To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Tuesday

Applied Materials To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Palo Alto To Rally Around 30%? Here Are 10 Top Analyst Forecasts For Friday

Palo Alto To Rally Around 30%? Here Are 10 Top Analyst Forecasts For Friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Zoom To Rally Around 38%? Here Are 10 Top Analyst Forecasts For Tuesday

Zoom To Rally Around 38%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Robinhood To Rally More Than 20%? Here Are 10 Top Analyst Forecasts For Thursday

Robinhood To Rally More Than 20%? Here Are 10 Top Analyst Forecasts For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Nvidia To Rally Around 73%? Here Are 10 Top Analyst Forecasts For Monday

Nvidia To Rally Around 73%? Here Are 10 Top Analyst Forecasts For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Rocket Lab Stock Dips 14%—Buying Opportunity Ahead?

Rocket Lab Stock Dips 14%—Buying Opportunity Ahead?

Ahead of Q3 earnings, Rocket Lab shares have cooled after a massive rally, dipping roughly 14% from recent highs but remaining up over 150% year-to-date.

Wall Street Says This 1 Little-Known Stock Could Be a Rare Earth ‘Winner’

Wall Street Says This 1 Little-Known Stock Could Be a Rare Earth ‘Winner’

A little-known company with rare earth exposure is gaining attention on Wall Street as analysts position it as a potential long-term winner in America’s critical minerals push.

Get all your
news in one place.

100’s of premium titles.
One news app.

SLB To Rally Around 44%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Rocket Lab USA Receives Wall Street Validation: Time to Buy?

Baird and Morgan Stanley issued bullish upgrades as Rocket Lab extended its flawless Electron launch streak and secured new JAXA contracts.

Rocket Lab Stock Is Sliding Thursday: What's Going On?

Rocket Lab Corp (NASDAQ:RKLB) shares are trading lower Thursday afternoon, despite positive analyst coverage from Baird. The stock is potentially trading lower amid overall market weakness.

Boston Scientific To Rally More Than 35%? Here Are 10 Top Analyst Forecasts For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Get all your
news in one place.

100’s of premium titles.
One news app.

Tesla Robotaxis Could Be Coming Soon to Arizona. Should You Buy, Sell, or Hold TSLA Stock Here?

With Tesla’s robotaxis rolling into Arizona and autonomous ambitions heating up, could the stock be cruising toward a breakout, or is it a pit stop moment for investors?

UnitedHealth's Crown Jewel At Risk: Analyst Warns Optum Health Could Be 'Structurally Impaired' By Medicare Rule Changes

A leading Managed Care Analyst at Baird, Michael Ha, has a warning against UnitedHealth Group Inc.’s (NYSE:UNH) prized Optum Health division, which he believes could see headwinds as a result of recent government changes to Medicare Advantage risk coding.

Tesla To Rally More Than 31%? Here Are 10 Top Analyst Forecasts For Friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Goldman Sachs To Rally around 9%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Apple To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Roblox To Rally Around 34%? Here Are 10 Top Analyst Forecasts For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Alphabet To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

People

David Chiaverini

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

334,157 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play